2 Under-the-Radar Stocks to Buy and Hold
Source: Motley Fool
2026-03-10 13:33:00 ET
Popular companies aren't always great investments, and little-known corporations sometimes are. Those in the latter group may even be underpriced, given that they receive less attention and analyst coverage than their larger, more prominent peers, creating attractive opportunities for investors.
Let's consider two under-the-radar stocks that are worth serious consideration for long-term investors: Axsome Therapeutics (NASDAQ: AXSM) and Madrigal Pharmaceuticals (NASDAQ: MDGL) .
Image source: Getty Images.
Madrigal Pharmaceuticals Inc.
NASDAQ: MDGL
MDGL Trading
0.31% G/L:
$431.65 Last:
73,972 Volume:
$427.275 Open:
MDGL Latest News
February 24, 2026 08:00:00 am
Madrigal Pharmaceuticals to Participate in the TD Cowen 46th Annual Health Care Conference
February 19, 2026 07:00:00 am
Madrigal Pharmaceuticals Reports Fourth-Quarter and Full-Year 2025 Financial Results
MDGL Stock Data
$10,921,013,421
11,446,556
2.73%
146
N/A
Biotechnology & Life Sciences
Healthcare
US
West Conshohocken
